The import of blood-grouping reagents to South Africa has seen varied trends from 2013 to 2023. Starting at 630.69 thousand USD in 2013, the import value saw significant fluctuations, notably a dip in 2015 and a subsequent recovery. By 2023, the imports stood at 1047.0 thousand USD. The year-on-year variation for the latest observed year (2023) was a moderate 3.12%, demonstrating stable growth after a period of significant volatility. Over the past five years leading up to 2023, the CAGR was 3.85%, indicating a steady annual growth rate.

Looking ahead, from 2024 onwards, the import values are forecasted to grow, reaching 1196.0 thousand USD by 2028, which translates to a CAGR of 2.1% over the five-year forecast period. This forecasted period is marked by a projected total growth rate of 10.94%.

Future trends to watch for include:

Technological advancements in blood-grouping reagents that might impact import values.
Changes in healthcare policies and budget allocations in South Africa.
Potential market disruptions due to global economic factors or supply chain challenges.
Increased demand driven by advancements in medical research and population health initiatives.